Literature DB >> 20128670

Olfaction in the elderly: a cross-sectional analysis comparing Parkinson's disease with controls and other disorders.

Jonathan McKinnon1, Virgilio Evidente, Erika Driver-Dunckley, Ashvini Premkumar, Joseph Hentz, Holly Shill, Marwan Sabbagh, John Caviness, Donald Connor, Charles Adler.   

Abstract

Olfactory dysfunction in Parkinson's disease (PD) is an association that has been well documented in the medical literature, although the underlying pathophysiologic mechanism has not been clearly elucidated. In the Sun Health Research Institute Brain and Body Donation Program, subjects were tested for olfactory function. Olfaction was impaired in subjects with clinically probable PD but not those with essential tremor (ET), restless legs syndrome (RLS), or mild cognitive impairment. In the elderly control population there were no differences between genders and the UPSIT score decreased by 3.2 points per decade. These data confirm previous findings in PD, ET, and RLS, and expand the data for an elderly control population.

Entities:  

Mesh:

Year:  2010        PMID: 20128670     DOI: 10.3109/00207450903428954

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  18 in total

1.  Autonomic function, as self-reported on the SCOPA-autonomic questionnaire, is normal in essential tremor but not in Parkinson's disease.

Authors:  Anne Damian; Charles H Adler; Joseph G Hentz; Holly A Shill; John N Caviness; Marwan N Sabbagh; Virgilio G H Evidente; Thomas G Beach; Erika Driver-Dunckley
Journal:  Parkinsonism Relat Disord       Date:  2012-07-06       Impact factor: 4.891

2.  A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative Diseases.

Authors:  Brittany N Dugger; Michael Malek-Ahmadi; Sarah E Monsell; Walter A Kukull; Bryan K Woodruff; Eric M Reiman; Thomas G Beach; Jeffrey Wilson
Journal:  Alzheimer Dis Assoc Disord       Date:  2016 Jul-Sep       Impact factor: 2.703

3.  Essential tremor and Parkinson's disease: lack of a link.

Authors:  Charles H Adler; Holly A Shill; Thomas G Beach
Journal:  Mov Disord       Date:  2011-01-31       Impact factor: 10.338

Review 4.  Essential tremor--a neurodegenerative disorder associated with cognitive defects?

Authors:  Félix Bermejo-Pareja
Journal:  Nat Rev Neurol       Date:  2011-04-12       Impact factor: 42.937

5.  Transcranial sonography and the pocket smell test in the differential diagnosis between parkinson's disease and essential tremor.

Authors:  Ivanka Štenc Bradvica; Ivan Mihaljević; Silva Butković-Soldo; Dragutin Kadojić; Marina Titlić; Mario Bradvica; Kristina Kralik
Journal:  Neurol Sci       Date:  2015-03-19       Impact factor: 3.307

6.  Magnetization transfer imaging in premanifest and manifest Huntington disease.

Authors:  S J A van den Bogaard; E M Dumas; J Milles; R Reilmann; J C Stout; D Craufurd; M A van Buchem; J van der Grond; R A C Roos
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

Review 7.  Distinguishing essential tremor from Parkinson's disease: bedside tests and laboratory evaluations.

Authors:  Mary Ann Thenganatt; Elan D Louis
Journal:  Expert Rev Neurother       Date:  2012-06       Impact factor: 4.618

Review 8.  Neuropathological basis of nonmotor manifestations of Parkinson's disease.

Authors:  Charles H Adler; Thomas G Beach
Journal:  Mov Disord       Date:  2016-03-31       Impact factor: 10.338

9.  Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study.

Authors:  Charles H Adler; Thomas G Beach; Joseph G Hentz; Holly A Shill; John N Caviness; Erika Driver-Dunckley; Marwan N Sabbagh; Lucia I Sue; Sandra A Jacobson; Christine M Belden; Brittany N Dugger
Journal:  Neurology       Date:  2014-06-27       Impact factor: 9.910

10.  Premotor biomarkers for Parkinson's disease - a promising direction of research.

Authors:  Brian R Haas; Tessandra H Stewart; Jing Zhang
Journal:  Transl Neurodegener       Date:  2012-05-31       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.